Showing results (2311-2320 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|October 7, 2022
Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell CarcinomaHuizhu Qiu, Guojian Gu, Erdong Zuo, et al.Cancer Investigation|September 8, 2022
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsPerry B Hooper, Aaron S Farberg, Alison L Fitzgerald, et al.Cancer Investigation|January 1, 1987
Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesisH Roché, G Hyman, G Nahas, et al.Cancer Investigation|January 10, 2022
Prevalence and Risk Factors of QTc Prolongation in Prostate Cancer Patients Undergoing BrachytherapySimon Saad, Guila Delouya, Carole Lambert, et al.Cancer Investigation|June 9, 2011
Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibilityAnup R Tilak, Sachin Kumar, Meenu Jain, et al.Cancer Investigation|January 1, 1990
Resistance of tumor-derived DNA to restriction enzyme digestionJ L Parkes, F C Hubbard, A PennCancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.Cancer Investigation|July 12, 2011
Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse eventsShenhong Wu, Roger S KeresztesCancer Investigation|July 12, 2011
Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expressionJochen Winter, Annette Pantelis, Rudolf Reich, et al.Cancer Investigation|January 1, 1989
Opportunities for cancer research in a Health Maintenance OrganizationA G Glass, M R GreenlickPageof 294